Moreover, lower TENM4 expression in human ovarian cancer has been more highly associated with undifferentiated tissues than differentiated ones and with reduced ovarian cancer cells’ sensitivity to cisplatin, demonstrating that, in this type of tumor, lower TENM4 expression correlates with worse patient prognosis and possibly with tumor chemoresistance [43]. This evidence concerns the gene TENM4 and neoplasm.